Our findings suggest the specificity of YKL-40 in atherosclerosis, especially in patients suffering from CagA+ HP infection, indicating that YKL-40 may serve as a predictive biomarker for plaque instability in carotid atherosclerosis with CagA+ HP infection. Here, S100A8 is linked to carotid atherosclerosis.